What is Esperion Therapeutics's other financing?

Esperion Therapeutics (ESPR) reported other financing of $61K in Q4 2025.

How has Esperion Therapeutics's other financing changed year-over-year?

Esperion Therapeutics's other financing increased by 741.4% year-over-year, from $7.25K to $61K.

What is the long-term trend for Esperion Therapeutics's other financing?

Over 3 years (2022 to 2025), Esperion Therapeutics's other financing has grown at a 3.7% compound annual growth rate (CAGR), from -$219K to $244K.

What does other financing mean?

Miscellaneous financing cash flows not classified in specific line items.

Esperion Therapeutics ESPR Other Financing

Other Financing at other companies

AmgenAMGN

-$104M-285%

ViatrisVTRS

-$300K+99.7%

Other financials

Income statement

See full

Revenue$80.1M+23.2%

Operating income-$6.6M+70.2%

Net income-$25.2M+37.7%

EPS (diluted)-$0.10+52.4%

Balance sheet

See full

Cash & equivalents$156.2M+36.2%

Total debt$155.2M+6.1%

Total equity-$307.9M+27.8%

Total assets$462.5M+42.7%

Cash flow

See full

Operating cash flow-$27.7M-22.5%

CapEx$189.0K—

Free cash flow-$27.9M-23.3%

Valuation

See full

Market cap$811.73M+283%

Enterprise value$810.81M+233%

P/S1.9×+1.1×

Profitability

See full

Operating margin18.1%+12.7pp

Net margin-34.8%+8.0pp

FCF margin-30.7%—

Returns & leverage

See full

Return on equity-260.8%—

Debt / equity0.8×—

Current ratio1.5×+0.4×

Where this comes from

Reported directly by Esperion Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromPaymentsForOtherFinancingActivities.

The official record: Esperion Therapeutics’s 10-K, filed March 10, 2026, on SEC EDGAR. View the filing →

Ask your AI about Esperion Therapeutics's other financing.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Esperion Therapeutics's other financing?: Esperion Therapeutics (ESPR) reported other financing of $61K in Q4 2025.
How has Esperion Therapeutics's other financing changed year-over-year?: Esperion Therapeutics's other financing increased by 741.4% year-over-year, from $7.25K to $61K.
What is the long-term trend for Esperion Therapeutics's other financing?: Over 3 years (2022 to 2025), Esperion Therapeutics's other financing has grown at a 3.7% compound annual growth rate (CAGR), from -$219K to $244K.
What does other financing mean?: Miscellaneous financing cash flows not classified in specific line items.